rs199422213

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate

The NM_000295.5(SERPINA1):​c.326C>T​(p.Thr109Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,612,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T109S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 0 hom. )

Consequence

SERPINA1
NM_000295.5 missense

Scores

2
11
6

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:2O:1

Conservation

PhyloP100: 2.24

Publications

10 publications found
Variant links:
Genes affected
SERPINA1 (HGNC:8941): (serpin family A member 1) The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020]
SERPINA1 Gene-Disease associations (from GenCC):
  • alpha 1-antitrypsin deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cystic fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.871

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINA1NM_000295.5 linkc.326C>T p.Thr109Met missense_variant Exon 2 of 5 ENST00000393087.9 NP_000286.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINA1ENST00000393087.9 linkc.326C>T p.Thr109Met missense_variant Exon 2 of 5 1 NM_000295.5 ENSP00000376802.4 P01009-1

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152230
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000279
AC:
7
AN:
251266
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000440
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000294
AC:
43
AN:
1460476
Hom.:
0
Cov.:
32
AF XY:
0.0000344
AC XY:
25
AN XY:
726274
show subpopulations
African (AFR)
AF:
0.0000599
AC:
2
AN:
33386
American (AMR)
AF:
0.00
AC:
0
AN:
44636
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39672
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000333
AC:
37
AN:
1110914
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000656
AC:
10
AN:
152348
Hom.:
0
Cov.:
33
AF XY:
0.0000805
AC XY:
6
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41586
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000385
AC:
2
AN:
5190
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000334
Hom.:
0
Bravo
AF:
0.0000453
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Alpha-1-antitrypsin deficiency Pathogenic:1Uncertain:1
Mar 24, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 08, 2014
Department of Laboratory Medicine and Genetics, Trillium Health Partners Credit Valley Hospital
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:curation

- -

not provided Uncertain:1
Feb 04, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PI Z(BRISTOL) Other:1
Jul 15, 2016
OMIM
Significance:other
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
0.10
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
T;T;T;T;T;T;T;T;T;.;.;.;T;T
Eigen
Benign
0.10
Eigen_PC
Benign
-0.071
FATHMM_MKL
Benign
0.58
D
LIST_S2
Uncertain
0.94
.;.;.;D;.;.;.;.;.;D;T;.;.;.
M_CAP
Uncertain
0.12
D
MetaRNN
Pathogenic
0.87
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.69
D
MutationAssessor
Pathogenic
3.6
H;H;H;H;H;H;H;H;H;H;.;.;.;.
PhyloP100
2.2
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-4.3
D;D;D;D;D;.;D;D;D;D;D;D;D;D
REVEL
Uncertain
0.59
Sift
Uncertain
0.0010
D;D;D;D;D;.;D;D;D;D;D;D;T;D
Sift4G
Uncertain
0.0020
D;D;D;D;D;.;D;D;D;D;.;.;.;D
Polyphen
0.98
D;D;D;D;D;D;D;D;D;D;.;.;.;.
Vest4
0.83
MutPred
0.76
Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);.;Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);Loss of glycosylation at T109 (P = 0.054);
MVP
0.97
MPC
0.29
ClinPred
0.98
D
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.44
gMVP
0.50
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199422213; hg19: chr14-94849249; COSMIC: COSV63345347; COSMIC: COSV63345347; API